RecruitingNot Applicable

Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter

Israel250 participantsStarted 2020-06-15

Plain-language summary

In this clinical study the investigators will compare blood pressure measurements obtained using the non-invasive, wireless Biobeat monitoring device (both a wrist watch and a patch configuration) to an invasive arterial line catheter (radial or femoral) and a Swan Ganz Catheter in 20 patients immediately after cardiac surgery, at the cardiac intensive care unit.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years old and above patients of both sexes arriving immediately after cardiac surgery to the intensive care unit with a radial/femoral arterial line and or a Swan Ganz catheter and in need for blood pressure monitoring. Exclusion Criteria: * Refusal to participate * Patients with no need or no technical capability to have an arterial line * Pregnant women * Individuals under the age of 18 years * Patients with lack of judgment/mental illness * Patients working in the Sheba Medical Center

What they're measuring

Level of accordance between the Biobeat monitor and the arterial line

Timeframe: 4 hours per individual

Trial details

NCT IDNCT04071015

SponsorBiobeat Technologies Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-11

Contact for this trial

Arik Eisenkraft, MD, MHA

+972-52-9210896 dr.arik@bio-beat.gov

View on ClinicalTrials.gov More Blood Pressure trials